Atlas Venture Associates Opportunity I, L.p. - Net Worth and Insider Trading
Atlas Venture Associates Opportunity I, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Atlas Venture Associates Opportunity I, L.p. owns 13 companies in total, including Dyne Therapeutics Inc (DYN) , Kymera Therapeutics Inc (KYMR) , and Magenta Therapeutics Inc (MGTA) among others .
Insider Ownership Summary of Atlas Venture Associates Opportunity I, L.p.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
DYN | Dyne Therapeutics Inc | 2020-09-16 | 10 percent owner |
KYMR | Kymera Therapeutics Inc | 2020-08-20 | 10 percent owner |
MGTA | Magenta Therapeutics Inc | 2020-06-29 | other: See remarks |
2020-06-11 | 10 percent owner | ||
2019-11-18 | other: See Remarks | ||
2019-07-19 | other: See Remarks | ||
2019-06-19 | 10 percent owner | ||
2022-12-29 | 10 percent owner | ||
2022-01-06 | 10 percent owner | ||
2021-03-25 | 10 percent owner | ||
2021-10-21 | 10 percent owner | ||
2021-05-26 | 10 percent owner | ||
2022-09-14 | 10 percent owner |
Atlas Venture Associates Opportunity I, L.p. Trading Performance
Atlas Venture Associates Opportunity I, L.p. Ownership Network
Ownership Network List of Atlas Venture Associates Opportunity I, L.p.
Ownership Network Relation of Atlas Venture Associates Opportunity I, L.p.
Atlas Venture Associates Opportunity I, L.p. Owned Company Details
What does Dyne Therapeutics Inc do?
Who are the key executives at Dyne Therapeutics Inc?
Atlas Venture Associates Opportunity I, L.p. is the 10 percent owner of Dyne Therapeutics Inc. Other key executives at Dyne Therapeutics Inc include See Remarks Oxana Beskrovnaya , See Remarks Richard William Scalzo , and Chief Medical Officer Wildon Farwell .
Dyne Therapeutics Inc (DYN) Insider Trades Summary
Over the past 18 months, Atlas Venture Associates Opportunity I, L.p. made no insider transaction in Dyne Therapeutics Inc (DYN). Other recent insider transactions involving Dyne Therapeutics Inc (DYN) include a net sale of 244,099 shares made by Jonathan Mcneill , a net sale of 194,534 shares made by Richard William Scalzo , and a net sale of 133,322 shares made by Oxana Beskrovnaya .
In summary, during the past 3 months, insiders sold 921,534 shares of Dyne Therapeutics Inc (DYN) in total and bought 0 shares, with a net sale of 921,534 shares. During the past 18 months, 5,516,515 shares of Dyne Therapeutics Inc (DYN) were sold and 3,583,447 shares were bought by its insiders, resulting in a net sale of 1,933,068 shares.
Dyne Therapeutics Inc (DYN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dyne Therapeutics Inc Insider Transactions
Atlas Venture Associates Opportunity I, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Atlas Venture Associates Opportunity I, L.p.. You might contact Atlas Venture Associates Opportunity I, L.p. via mailing address: 400 Technology Square, 10th Floor, Cambridge Ma 02139.